Early Screening
One Step Dementia Risk Test Kit
Sensivity 75.7%，Specificity 91.03%
First Globally
Clinically approved
Accurate
Non-invasive
Fast: 10 Mins have the result
Auxiliary Diagnosis
chemiluminescence detection reagent
Quantitative detection of trace amounts of beta-amyloid in urine using highly specific antibodies
Somatic gene detection model
Accurate prediction of future Alzheimer's disease in middle-aged individuals using molecular diagnostics and big data models
Interventional Therapy
Traditional Chinese Medicine Capsule
From the screening of thousands of traditional Chinese medicines, traditional Chinese medicines with excellent early intervention effect on AD have been found, which can effectively block the development of AD. At present, super-professional equipment has been purchased and is being tested, and the production line is also under construction. It is expected to be listed in 2025.
Therapeutic Drug
By increasing the natural phagocytic capacity of scavenger receptors on human monocytes, including P2X7, a new therapy is expected to completely cure Alzheimer's disease.
Domestic business consulting Tel:+86-731-85714218
E-mail:yingxiao@qankorey.com
Internation Marketing Tel:+86-18874232226
E-mail:lisa@qankorey.com
Company address: 12F, Building 15, No.188 Middle Huanbao Road, Yuhua District, Changsha, Hunan, China 410116
Production Address: 4/F, Building 7, Yuhua Intelligent Manufacturing Center, No.2 Hongda Road, Tongsheng Street, Yuhua District, Changsha,Hunan China,410007
Public Number
Small program
Jingdong
Taobao